Prestige Consumer Healthcare/PBH

$64.92

-0.09%
-
1D1W1MYTD1YMAX

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.

Ticker

PBH

Sector

Healthcare

Trading on

NYSE

Industry

Retail (Drugs)

CEO

Ronald Lombardi

Employees

570

Headquarters

Tarrytown, United States

PBH Metrics

BasicAdvanced
$3.3B
Market cap
-
P/E ratio
-$1.64
EPS
0.50
Beta
-
Dividend rate
$3.3B
0.50402
$75.31
$52.90
230K
3.09
1.924
74.944
75.081
4.93%
-2.28%
-4.91%
-2.37%
2.909
2.062
14.22
2.29%
-139.44%
5.4%

What the Analysts think about PBH

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
14.91% upside
High $81.00
Low $65.00
$64.92
Current price
$74.60
Average price target

PBH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
18.74% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$283M
-1.26%
Net income
$53M
-0.93%
Profit margin
18.74%
0.32%

PBH Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.09%
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$1.06
$1.07
$1.06
$0.98
-
Expected
$1.01
$1.07
$1.04
$1.14
$1.12
Surprise
4.99%
0.34%
1.81%
-14.09%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Prestige Consumer Healthcare stock?

Prestige Consumer Healthcare (PBH) has a market cap of $3.2B as of May 20, 2024.

What is the P/E ratio for Prestige Consumer Healthcare stock?

The price to earnings (P/E) ratio for Prestige Consumer Healthcare (PBH) stock is 15.5 as of May 20, 2024.

Does Prestige Consumer Healthcare stock pay dividends?

No, Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders as of May 20, 2024.

When is the next Prestige Consumer Healthcare dividend payment date?

Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders.

What is the beta indicator for Prestige Consumer Healthcare?

Prestige Consumer Healthcare (PBH) has a beta rating of 0.5. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Prestige Consumer Healthcare stock price target?

The target price for Prestige Consumer Healthcare (PBH) stock is $74.6, which is 15.39% above the current price of $64.65. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Prestige Consumer Healthcare stock

Buy or sell Prestige Consumer Healthcare stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing